+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Bioelectric Medicine Market Size, Share & Industry Trends Analysis Report By Type (Implantable Electroceutical Devices, and Non-invasive Electroceutical Devices), By End-use, By Product, By Application, By Regional Outlook and Forecast, 2023 - 2030

  • PDF Icon

    Report

  • 372 Pages
  • December 2023
  • Region: Global
  • Marqual IT Solutions Pvt. Ltd (KBV Research)
  • ID: 5922438
The Global Bioelectric Medicine Market size is expected to reach $31.7 billion by 2030, rising at a market growth of 6.1% CAGR during the forecast period.

Deep brain stimulation (DBS) is a well-established technique involving implanted electrodes to deliver electrical impulses to specific brain regions, providing therapeutic benefits in conditions like Parkinson's disease. Therefore, Deep Brain Stimulators segment generated $1,022.1 million revenue in the market in 2022. Likewise, neuromodulation techniques, such as transcranial magnetic stimulation (TMS), and deep brain stimulation, are being explored for their potential in various neurological and psychiatric disorders. These techniques aim to modulate neural activity to restore normal functioning and alleviate symptoms. These aspects will lead to increased demand in the market.

The major strategies followed by the market participants are Partnerships, Collaborations & Agreements as the key developmental strategy to keep pace with the changing demands of end users. For instance, In August, 2021, electroCore, Inc. signed an agreement with Red One Medical Devices, LLC, a service-disabled veteran-owned small business. This agreement aimed to widen the availability of electroCore’s gammaCore platform in the federal marketplace. Moreover, In May, 2020, Medtronic collaborated with UW following which the company has accelerated research into deep brain stimulation treatment for essential tremor, Parkinson’s disease, and other neurological disorders.

Cardinal Matrix - Market Competition Analysis

Based on the Analysis presented in the Cardinal Matrix; Abbott Laboratories and Medtronic PLC are the forerunners in the Market. In November, 2021, Medtronic PLC partnered with Rune Labs, a company using aggregated brain data to empower the development and delivery of precision medicines for neurological and psychiatric diseases. This partnership aimed to assess the use of BrainSense technology, the first and only complete Deep Brain Stimulation system able to chronically capture and record brain signals. Companies such as Boston Scientific Corporation, Nevro Corporation and electroCore, Inc. are some of the key innovators in the Market.

COVID-19 Impact Analysis

The pandemic disrupted global supply chains, affecting the production and distribution of bioelectric devices and components. Lockdowns, travel restrictions, and workforce challenges led to delays in manufacturing and supply, impacting the availability of certain bioelectric technologies. Many research and development activities in the market experienced delays as laboratories were temporarily closed, and resources were redirected toward COVID-19-related research. Clinical trials for new bioelectric therapies faced interruptions, affecting timelines for product development. Therefore, the COVID-19 pandemic led to a negative impact on the market.

Market Growth Factors

Growing aging population globally

The aging process is associated with an increased risk of chronic diseases such as cardiovascular disorders, neurodegenerative conditions (like Alzheimer's and Parkinson's diseases), arthritis, and other age-related ailments. Bioelectric interventions, through their potential to modulate physiological processes, can offer novel approaches to manage and treat these conditions effectively. Bioelectric medicine aims not only to treat diseases but also to enhance the overall quality of life. Bioelectric interventions, including neuromodulation and other techniques, can improve these aspects and promote a better quality of life for elderly individuals. These factors will help in the expansion of the market.

Rising investments in research and development

Investment in research helps navigate regulatory pathways for approval and commercialization. Meeting regulatory standards is crucial for bringing bioelectric therapies to the market, and ongoing investment supports the necessary studies and documentation to meet these requirements. The commitment of resources from industry leaders contributes to expanding the market. As new therapies are developed and proven effective, they can reach a broader patient population, increasing market penetration. Therefore, these factors will pose lucrative growth prospects for the market.

Market Restraining Factors

Challenges related to regulatory approval

Bioelectric companies looking to market their products internationally face the challenge of navigating multiple regulatory frameworks. Differences in approval processes and requirements across regions can add complexity and length to the overall regulatory timeline. Regulatory agencies may face challenges in adapting existing frameworks to accommodate rapidly evolving technologies in bioelectric medicine. The novelty and uniqueness of some bioelectric therapies may require regulatory agencies to develop specialized guidelines. These elements will hamper the growth of the market.

Type Outlook

By type, the market is bifurcated into implantable electroceutical devices and non-invasive electroceutical devices. In 2022, the non-invasive electroceutical devices segment witnessed a substantial revenue share in the market. Non-invasive electroceutical devices provide a patient-friendly alternative to invasive procedures. Patients often prefer non-invasive treatments due to reduced pain, minimal discomfort, and the absence of surgical interventions. This approach enhances patient compliance and contributes to a positive patient experience. Technological advancements have been crucial in developing sophisticated, non-invasive electroceutical devices. Innovative technologies, such as transdermal electrical stimulation and non-invasive neuromodulation, have expanded the scope of non-invasive interventions. Therefore, the segment will expand rapidly in the upcoming years.

End-use Outlook

On the basis of end-use, the market is divided into hospitals and others. The hospitals segment recorded the maximum revenue share in the market in 2022. Bioelectric interventions are finding applications across various medical specialties, ranging from neurology and pain management to cardiology and rehabilitation. The versatility of bioelectric therapies makes them relevant for addressing diverse medical conditions, prompting hospitals to explore and implement these interventions within various departments. Thus, these factors will fuel the growth of the hospitals segment.

Product Outlook

Based on product, the market is segmented into implantable cardioverter defibrillators & cardiac pacemakers, cochlear implants, spinal cord stimulators, deep brain stimulators, transcutaneous electrical nerve stimulators, sacral & vagus nerve stimulators, and others. In 2022, the spinal cord stimulators segment garnered a significant revenue share in the market. Spinal cord stimulators are often used as a therapeutic option for managing chronic pain conditions, such as failed back surgery syndrome and complex regional pain syndrome. The rising prevalence of these conditions, coupled with a growing aging population, can contribute to an increased demand for spinal cord stimulators. Therefore, the segment will expand rapidly in the coming years.

Application Outlook

Based on application, the market is divided into arrhythmia, pain management, sensorineural hearing loss, Parkinson’s disease, tremor & epilepsy, depression, treatment-resistant depression, urinary & fecal incontinence, and others. In 2022, the tremor and epilepsy segment witnessed a substantial revenue share in the market. Tremors and epilepsy often involve abnormal electrical activity in the brain. Neuromodulation therapies, a significant component of bioelectric medicine, involve the use of electrical stimulation to modulate neural activity. Advances in neuromodulation technologies may lead to more effective treatments for conditions such as tremors and epilepsy. These factors will lead to rapid expansion of the segment.

Regional Outlook

By region, the market is segmented into North America, Europe, Asia Pacific, and LAMEA. The North America segment procured the highest revenue share in the market in 2022. North America, particularly the United States, has been a significant player in the healthcare industry, with a robust industry for medical technologies and innovations. The region has been at the forefront of bioelectric medicine research and development. Academic institutions, research centers, and industry collaborations often drive innovation, leading to the development of novel bioelectric therapies and devices. Thus, the segment will witness increased growth in the coming years.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Medtronic PLC, Abbott Laboratories, Boston Scientific Corporation, Cochlear Ltd., LivaNova PLC, Koninklijke Philips N.V., Biotronik SE & Co. KG, Sonova Holding AG, Nevro Corporation, and electroCore, Inc.

Strategies deployed in the Market

» Partnerships, Collaborations and Agreements:

  • Nov-2021: Medtronic PLC partnered with Rune Labs, a company using aggregated brain data to empower the development and delivery of precision medicines for neurological and psychiatric diseases. This partnership aimed to assess the use of BrainSense technology, the first and only complete Deep Brain Stimulation system able to chronically capture and record brain signals.
  • Aug-2021: electroCore, Inc. signed an agreement with Red One Medical Devices, LLC, a service-disabled veteran-owned small business. This agreement aimed to widen the availability of electroCore’s gammaCore platform in the federal marketplace.
  • May-2020: Medtronic collaborated with UW following which the company has accelerated research into deep brain stimulation treatment for essential tremor, Parkinson’s disease, and other neurological disorders.
  • May-2019: Abbott came into partnership with the US National Institutes of Health (NIH). The partnership was aimed at developing unique insights and driving the application of neurostimulation therapies. The partnership would provide the latter company's neuroscience research initiative BRAIN access to Abbott’s neuromodulation technologies.

» Product Launches and Product Expansions:

  • Dec-2022: electroCore, Inc. rolled out Truvaga, a new wellness product offering. The launched product aimed to provide a drug-free, simple, and convenient way to support in reducing stress with just 2-minute sessions, day and night; no apps, batteries, chargers, or phones are required.
  • Nov-2022: electroCore, Inc. introduced gammaCore Sapphire, the first and only FDA-cleared non-invasive device. The launch would be aimed at treating and preventing multiple types of headache pain via the vagus nerve.
  • Oct-2020: Abbott Laboratories introduced ICD (Implantable Cardioverter-Defibrillator), a medical device that monitors heart rhythms and delivers shocks to treat life-threatening arrhythmias, and CRT-D (Cardiac Resynchronization Therapy with Defibrillation), an ICD with an added feature to synchronize the contractions of the heart's ventricles, improving heart function in certain patients.
  • Jan-2020: Medtronic announced the CE mark for its Percept PC neurostimulator. This is a Deep Brain Stimulation (DBS) system with BrainSense technology. The system can sense and record brain signals while offering therapy to patients with neurologic disorders, such as Parkinson’s disease.
  • Oct-2019: Medtronic launched Activa Programming, a new system. The system enables the patients in managing their deep brain stimulation (DBS) treatments at home using a dedicated and customized Samsung smartphone.
  • Jan-2019: Cochlear Ltd. launched Nucleus 7 Sound Processor, implantable hearing device for the people with single-sided deafness, conductive and mixed hearing loss.
  • Jan-2019: Boston launched WaveWriter Spinal Cord Stimulator (SCS) System in Europe for providing the treatment of chronic pain to people in Europe.
  • Jan-2019: Boston Scientific introduced the Vercise Primary Cell (PC) and Vercise Gevia Deep Brain Stimulation (DBS) Systems. The systems feature the Vercise Cartesia Directional Lead. The systems have the technology that enables the physicians in controlling the range, shape, position, and direction of electrical stimulation to treat the symptoms of Parkinson's disease (PD) through highly-personalized therapy.

» Acquisition and Mergers:

  • May-2022: Medtronic plc acquired Intersect ENT, a medical technology company. This acquisition aimed to increase Medtronic's comprehensive ear, nose, and throat offering with innovative products used in sinus procedures to enhance post-operative outcomes and treat nasal polyps.
  • Nov-2021: Koninklijke Philips N.V. acquired Cardiology, a France-based medical technology company focused on transforming cardiac diagnostics using artificial intelligence (AI) and cloud technology. Through his acquisition, Koninklijke Philips N.V. would be able to strengthen its diagnostics offering and cardiac monitoring with electrocardiogram (ECG) analysis, creative software technology, and reporting services.
  • Feb-2021: Koninklijke Philips N.V. took over BioTelemetry, Inc., a leading U.S.-based provider of remote cardiac diagnostics and monitoring. Through this acquisition, Koninklijke Philips N.V. would be in a favourable position to enhance patient care across care environments for medical conditions and numerous diseases with the help of the combination of both the organization's portfolio and service platforms.
  • Jan-2020: Medtronic took over Stimgenics, a startup company that has developed a novel spinal cord stimulation waveform. This acquisition enabled the company to expand its business in the SCS Market.
  • Jun-2019: Boston Scientific acquired Vertiflex, a healthcare company. Through this acquisition, Vertiflex's spinal cord stimulation and radiofrequency ablation have been added to Boston Scientific's product portfolio.

» Approvals and Trials

  • Jul-2023: Abbott Laboratories got approval from the FDA for the AVEIR dual chamber (DR) leadless pacemaker system, an advanced medical device that offers dual-chamber pacing capabilities without the need for traditional leads or wires, improving patient comfort and reducing potential complications.
  • Oct-2022: Nevro Corporation got FDA approval for the Senza HFX iQ spinal cord stimulation (SCS) system, the first and only Artificial Intelligence-based SCS system. The approved product would address the variability in pain from patient to patient and support patients to optimize and maintain long-term pain relief and improved quality of life.
  • Jan-2021: Medtronic plc introduced the first enrollment in ADAPT-PD. This trial aimed to evaluate the safety and efficacy of adaptive deep brain stimulation (aDBS) in patients with Parkinson's Disease.
  • Jan-2020: Abbott Laboratories got approval from the US Food and Drug Administration (FDA) for its Infinity Deep Brain Stimulation (DBS) system. This system would be used in the treatment of Parkinson’s disease. The system would enable targeting a specific area of the brain known as the internal globus pallidus (GPi) for improving the symptoms of Parkinson’s disease not controlled by medication.
  • Nov-2019: Nevro Corporation received approval from the FDA for the Senza Omnia Spinal Cord Stimulation (SCS) System. The Omnia system has been designed to deliver Nevro's proprietary HF10 therapy in addition to all other available SCS frequencies.

» Geographical Expansion

  • Sep-2019: Sonova opened a new training center in Germany. This expansion aimed to provide training program for hearing care professionals.
  • Mar-2019: Cochlear Ltd. expanded its reach to UK. This expansion aimed to provide the criteria for cochlear implant to professionals.

Scope of the Study

Market Segments Covered in the Report:

By Type
  • Implantable Electroceutical Devices
  • Non-invasive Electroceutical Devices
By End-use
  • Hospitals
  • Others
By Product
  • Implantable Cardioverter Defibrillators & Cardiac Pacemakers
  • Spinal Cord Stimulators
  • Cochlear Implants
  • Deep Brain Stimulators
  • Transcutaneous Electrical Nerve Stimulators
  • Sacral & Vagus Nerve Stimulators
  • Others
By Application
  • Arrhythmia
  • Pain Management
  • Sensorineural Hearing Loss
  • Tremor & Epilepsy
  • Parkinson’s Disease
  • Depression
  • Treatment-resistant Depression
  • Urinary & Fecal Incontinence
  • Others
By Geography
  • North America
  • US
  • Canada
  • Mexico
  • Rest of North America
  • Europe
  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe
  • Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Singapore
  • Malaysia
  • Rest of Asia Pacific
  • LAMEA
  • Brazil
  • Argentina
  • UAE
  • Saudi Arabia
  • South Africa
  • Nigeria
  • Rest of LAMEA

Key Market Players

List of Companies Profiled in the Report:

  • Medtronic PLC
  • Abbott Laboratories
  • Boston Scientific Corporation
  • Cochlear Ltd.
  • LivaNova PLC
  • Koninklijke Philips N.V.
  • Biotronik SE & Co. KG
  • Sonova Holding AG
  • Nevro Corporation
  • electroCore, Inc.

Unique Offerings

  • Exhaustive coverage
  • The highest number of Market tables and figures
  • Subscription-based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Table of Contents

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Global Bioelectric Medicine Market, by Type
1.4.2 Global Bioelectric Medicine Market, by End-use
1.4.3 Global Bioelectric Medicine Market, by Product
1.4.4 Global Bioelectric Medicine Market, by Application
1.4.5 Global Bioelectric Medicine Market, by Geography
1.5 Methodology for the research
Chapter 2. Market at a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
Chapter 4. Competition Analysis - Global
4.1 Cardinal Matrix
4.2 Recent Industry Wide Strategic Developments
4.2.1 Partnerships, Collaborations and Agreements
4.2.2 Product Launches and Product Expansions
4.2.3 Acquisition and Mergers
4.2.4 Geographical Expansions
4.2.5 Approvals and trials
4.3 Top Winning Strategies
4.3.1 Key Leading Strategies: Percentage Distribution (2019-2023)
4.3.2 Key Strategic Move: (Partnerships, Collaborations & Agreements: 2019, May - 2021, Nov) Leading Players
4.4 Porter’s Five Force Analysis
Chapter 5. Global Bioelectric Medicine Market by Type
5.1 Global Implantable Electroceutical Devices Market by Region
5.2 Global Non-invasive Electroceutical Devices Market by Region
Chapter 6. Global Bioelectric Medicine Market by End-use
6.1 Global Hospitals Market by Region
6.2 Global Others Market by Region
Chapter 7. Global Bioelectric Medicine Market by Product
7.1 Global Implantable Cardioverter Defibrillators & Cardiac Pacemakers Market by Region
7.2 Global Spinal Cord Stimulators Market by Region
7.3 Global Cochlear Implants Market by Region
7.4 Global Deep Brain Stimulators Market by Region
7.5 Global Transcutaneous Electrical Nerve Stimulators Market by Region
7.6 Global Sacral & Vagus Nerve Stimulators Market by Region
7.7 Global Others Market by Region
Chapter 8. Global Bioelectric Medicine Market by Application
8.1 Global Arrhythmia Market by Region
8.2 Global Pain Management Market by Region
8.3 Global Sensorineural Hearing Loss Market by Region
8.4 Global Tremor & Epilepsy Market by Region
8.5 Global Parkinson’s Disease Market by Region
8.6 Global Depression Market by Region
8.7 Global Treatment-resistant Depression Market by Region
8.8 Global Urinary & Fecal Incontinence Market by Region
8.9 Global Others Market by Region
Chapter 9. Global Bioelectric Medicine Market by Region
9.1 North America Bioelectric Medicine Market
9.1.1 North America Bioelectric Medicine Market by Type
9.1.1.1 North America Implantable Electroceutical Devices Market by Region
9.1.1.2 North America Non-invasive Electroceutical Devices Market by Region
9.1.2 North America Bioelectric Medicine Market by End-use
9.1.2.1 North America Hospitals Market by Region
9.1.2.2 North America Others Market by Region
9.1.3 North America Bioelectric Medicine Market by Product
9.1.3.1 North America Implantable Cardioverter Defibrillators & Cardiac Pacemakers Market by Country
9.1.3.2 North America Spinal Cord Stimulators Market by Country
9.1.3.3 North America Cochlear Implants Market by Country
9.1.3.4 North America Deep Brain Stimulators Market by Country
9.1.3.5 North America Transcutaneous Electrical Nerve Stimulators Market by Country
9.1.3.6 North America Sacral & Vagus Nerve Stimulators Market by Country
9.1.3.7 North America Others Market by Country
9.1.4 North America Bioelectric Medicine Market by Application
9.1.4.1 North America Arrhythmia Market by Country
9.1.4.2 North America Pain Management Market by Country
9.1.4.3 North America Sensorineural Hearing Loss Market by Country
9.1.4.4 North America Tremor & Epilepsy Market by Country
9.1.4.5 North America Parkinson’s Disease Market by Country
9.1.4.6 North America Depression Market by Country
9.1.4.7 North America Treatment-resistant Depression Market by Country
9.1.4.8 North America Urinary & Fecal Incontinence Market by Country
9.1.4.9 North America Others Market by Country
9.1.5 North America Bioelectric Medicine Market by Country
9.1.5.1 US Bioelectric Medicine Market
9.1.5.1.1 US Bioelectric Medicine Market by Type
9.1.5.1.2 US Bioelectric Medicine Market by End-use
9.1.5.1.3 US Bioelectric Medicine Market by Product
9.1.5.1.4 US Bioelectric Medicine Market by Application
9.1.5.2 Canada Bioelectric Medicine Market
9.1.5.2.1 Canada Bioelectric Medicine Market by Type
9.1.5.2.2 Canada Bioelectric Medicine Market by End-use
9.1.5.2.3 Canada Bioelectric Medicine Market by Product
9.1.5.2.4 Canada Bioelectric Medicine Market by Application
9.1.5.3 Mexico Bioelectric Medicine Market
9.1.5.3.1 Mexico Bioelectric Medicine Market by Type
9.1.5.3.2 Mexico Bioelectric Medicine Market by End-use
9.1.5.3.3 Mexico Bioelectric Medicine Market by Product
9.1.5.3.4 Mexico Bioelectric Medicine Market by Application
9.1.5.4 Rest of North America Bioelectric Medicine Market
9.1.5.4.1 Rest of North America Bioelectric Medicine Market by Type
9.1.5.4.2 Rest of North America Bioelectric Medicine Market by End-use
9.1.5.4.3 Rest of North America Bioelectric Medicine Market by Product
9.1.5.4.4 Rest of North America Bioelectric Medicine Market by Application
9.2 Europe Bioelectric Medicine Market
9.2.1 Europe Bioelectric Medicine Market by Type
9.2.1.1 Europe Implantable Electroceutical Devices Market by Country
9.2.1.2 Europe Non-invasive Electroceutical Devices Market by Country
9.2.2 Europe Bioelectric Medicine Market by End-use
9.2.2.1 Europe Hospitals Market by Country
9.2.2.2 Europe Others Market by Country
9.2.3 Europe Bioelectric Medicine Market by Product
9.2.3.1 Europe Implantable Cardioverter Defibrillators & Cardiac Pacemakers Market by Country
9.2.3.2 Europe Spinal Cord Stimulators Market by Country
9.2.3.3 Europe Cochlear Implants Market by Country
9.2.3.4 Europe Deep Brain Stimulators Market by Country
9.2.3.5 Europe Transcutaneous Electrical Nerve Stimulators Market by Country
9.2.3.6 Europe Sacral & Vagus Nerve Stimulators Market by Country
9.2.3.7 Europe Others Market by Country
9.2.4 Europe Bioelectric Medicine Market by Application
9.2.4.1 Europe Arrhythmia Market by Country
9.2.4.2 Europe Pain Management Market by Country
9.2.4.3 Europe Sensorineural Hearing Loss Market by Country
9.2.4.4 Europe Tremor & Epilepsy Market by Country
9.2.4.5 Europe Parkinson’s Disease Market by Country
9.2.4.6 Europe Depression Market by Country
9.2.4.7 Europe Treatment-resistant Depression Market by Country
9.2.4.8 Europe Urinary & Fecal Incontinence Market by Country
9.2.4.9 Europe Others Market by Country
9.2.5 Europe Bioelectric Medicine Market by Country
9.2.5.1 Germany Bioelectric Medicine Market
9.2.5.1.1 Germany Bioelectric Medicine Market by Type
9.2.5.1.2 Germany Bioelectric Medicine Market by End-use
9.2.5.1.3 Germany Bioelectric Medicine Market by Product
9.2.5.1.4 Germany Bioelectric Medicine Market by Application
9.2.5.2 UK Bioelectric Medicine Market
9.2.5.2.1 UK Bioelectric Medicine Market by Type
9.2.5.2.2 UK Bioelectric Medicine Market by End-use
9.2.5.2.3 UK Bioelectric Medicine Market by Product
9.2.5.2.4 UK Bioelectric Medicine Market by Application
9.2.5.3 France Bioelectric Medicine Market
9.2.5.3.1 France Bioelectric Medicine Market by Type
9.2.5.3.2 France Bioelectric Medicine Market by End-use
9.2.5.3.3 France Bioelectric Medicine Market by Product
9.2.5.3.4 France Bioelectric Medicine Market by Application
9.2.5.4 Russia Bioelectric Medicine Market
9.2.5.4.1 Russia Bioelectric Medicine Market by Type
9.2.5.4.2 Russia Bioelectric Medicine Market by End-use
9.2.5.4.3 Russia Bioelectric Medicine Market by Product
9.2.5.4.4 Russia Bioelectric Medicine Market by Application
9.2.5.5 Spain Bioelectric Medicine Market
9.2.5.5.1 Spain Bioelectric Medicine Market by Type
9.2.5.5.2 Spain Bioelectric Medicine Market by End-use
9.2.5.5.3 Spain Bioelectric Medicine Market by Product
9.2.5.5.4 Spain Bioelectric Medicine Market by Application
9.2.5.6 Italy Bioelectric Medicine Market
9.2.5.6.1 Italy Bioelectric Medicine Market by Type
9.2.5.6.2 Italy Bioelectric Medicine Market by End-use
9.2.5.6.3 Italy Bioelectric Medicine Market by Product
9.2.5.6.4 Italy Bioelectric Medicine Market by Application
9.2.5.7 Rest of Europe Bioelectric Medicine Market
9.2.5.7.1 Rest of Europe Bioelectric Medicine Market by Type
9.2.5.7.2 Rest of Europe Bioelectric Medicine Market by End-use
9.2.5.7.3 Rest of Europe Bioelectric Medicine Market by Product
9.2.5.7.4 Rest of Europe Bioelectric Medicine Market by Application
9.3 Asia Pacific Bioelectric Medicine Market
9.3.1 Asia Pacific Bioelectric Medicine Market by Type
9.3.1.1 Asia Pacific Implantable Electroceutical Devices Market by Country
9.3.1.2 Asia Pacific Non-invasive Electroceutical Devices Market by Country
9.3.2 Asia Pacific Bioelectric Medicine Market by End-use
9.3.2.1 Asia Pacific Hospitals Market by Country
9.3.2.2 Asia Pacific Others Market by Country
9.3.3 Asia Pacific Bioelectric Medicine Market by Product
9.3.3.1 Asia Pacific Implantable Cardioverter Defibrillators & Cardiac Pacemakers Market by Country
9.3.3.2 Asia Pacific Spinal Cord Stimulators Market by Country
9.3.3.3 Asia Pacific Cochlear Implants Market by Country
9.3.3.4 Asia Pacific Deep Brain Stimulators Market by Country
9.3.3.5 Asia Pacific Transcutaneous Electrical Nerve Stimulators Market by Country
9.3.3.6 Asia Pacific Sacral & Vagus Nerve Stimulators Market by Country
9.3.3.7 Asia Pacific Others Market by Country
9.3.4 Asia Pacific Bioelectric Medicine Market by Application
9.3.4.1 Asia Pacific Arrhythmia Market by Country
9.3.4.2 Asia Pacific Pain Management Market by Country
9.3.4.3 Asia Pacific Sensorineural Hearing Loss Market by Country
9.3.4.4 Asia Pacific Tremor & Epilepsy Market by Country
9.3.4.5 Asia Pacific Parkinson’s Disease Market by Country
9.3.4.6 Asia Pacific Depression Market by Country
9.3.4.7 Asia Pacific Treatment-resistant Depression Market by Country
9.3.4.8 Asia Pacific Urinary & Fecal Incontinence Market by Country
9.3.4.9 Asia Pacific Others Market by Country
9.3.5 Asia Pacific Bioelectric Medicine Market by Country
9.3.5.1 China Bioelectric Medicine Market
9.3.5.1.1 China Bioelectric Medicine Market by Type
9.3.5.1.2 China Bioelectric Medicine Market by End-use
9.3.5.1.3 China Bioelectric Medicine Market by Product
9.3.5.1.4 China Bioelectric Medicine Market by Application
9.3.5.2 Japan Bioelectric Medicine Market
9.3.5.2.1 Japan Bioelectric Medicine Market by Type
9.3.5.2.2 Japan Bioelectric Medicine Market by End-use
9.3.5.2.3 Japan Bioelectric Medicine Market by Product
9.3.5.2.4 Japan Bioelectric Medicine Market by Application
9.3.5.3 India Bioelectric Medicine Market
9.3.5.3.1 India Bioelectric Medicine Market by Type
9.3.5.3.2 India Bioelectric Medicine Market by End-use
9.3.5.3.3 India Bioelectric Medicine Market by Product
9.3.5.3.4 India Bioelectric Medicine Market by Application
9.3.5.4 South Korea Bioelectric Medicine Market
9.3.5.4.1 South Korea Bioelectric Medicine Market by Type
9.3.5.4.2 South Korea Bioelectric Medicine Market by End-use
9.3.5.4.3 South Korea Bioelectric Medicine Market by Product
9.3.5.4.4 South Korea Bioelectric Medicine Market by Application
9.3.5.5 Singapore Bioelectric Medicine Market
9.3.5.5.1 Singapore Bioelectric Medicine Market by Type
9.3.5.5.2 Singapore Bioelectric Medicine Market by End-use
9.3.5.5.3 Singapore Bioelectric Medicine Market by Product
9.3.5.5.4 Singapore Bioelectric Medicine Market by Application
9.3.5.6 Malaysia Bioelectric Medicine Market
9.3.5.6.1 Malaysia Bioelectric Medicine Market by Type
9.3.5.6.2 Malaysia Bioelectric Medicine Market by End-use
9.3.5.6.3 Malaysia Bioelectric Medicine Market by Product
9.3.5.6.4 Malaysia Bioelectric Medicine Market by Application
9.3.5.7 Rest of Asia Pacific Bioelectric Medicine Market
9.3.5.7.1 Rest of Asia Pacific Bioelectric Medicine Market by Type
9.3.5.7.2 Rest of Asia Pacific Bioelectric Medicine Market by End-use
9.3.5.7.3 Rest of Asia Pacific Bioelectric Medicine Market by Product
9.3.5.7.4 Rest of Asia Pacific Bioelectric Medicine Market by Application
9.4 LAMEA Bioelectric Medicine Market
9.4.1 LAMEA Bioelectric Medicine Market by Type
9.4.1.1 LAMEA Implantable Electroceutical Devices Market by Country
9.4.1.2 LAMEA Non-invasive Electroceutical Devices Market by Country
9.4.2 LAMEA Bioelectric Medicine Market by End-use
9.4.2.1 LAMEA Hospitals Market by Country
9.4.2.2 LAMEA Others Market by Country
9.4.3 LAMEA Bioelectric Medicine Market by Product
9.4.3.1 LAMEA Implantable Cardioverter Defibrillators & Cardiac Pacemakers Market by Country
9.4.3.2 LAMEA Spinal Cord Stimulators Market by Country
9.4.3.3 LAMEA Cochlear Implants Market by Country
9.4.3.4 LAMEA Deep Brain Stimulators Market by Country
9.4.3.5 LAMEA Transcutaneous Electrical Nerve Stimulators Market by Country
9.4.3.6 LAMEA Sacral & Vagus Nerve Stimulators Market by Country
9.4.3.7 LAMEA Others Market by Country
9.4.4 LAMEA Bioelectric Medicine Market by Application
9.4.4.1 LAMEA Arrhythmia Market by Country
9.4.4.2 LAMEA Pain Management Market by Country
9.4.4.3 LAMEA Sensorineural Hearing Loss Market by Country
9.4.4.4 LAMEA Tremor & Epilepsy Market by Country
9.4.4.5 LAMEA Parkinson’s Disease Market by Country
9.4.4.6 LAMEA Depression Market by Country
9.4.4.7 LAMEA Treatment-resistant Depression Market by Country
9.4.4.8 LAMEA Urinary & Fecal Incontinence Market by Country
9.4.4.9 LAMEA Others Market by Country
9.4.5 LAMEA Bioelectric Medicine Market by Country
9.4.5.1 Brazil Bioelectric Medicine Market
9.4.5.1.1 Brazil Bioelectric Medicine Market by Type
9.4.5.1.2 Brazil Bioelectric Medicine Market by End-use
9.4.5.1.3 Brazil Bioelectric Medicine Market by Product
9.4.5.1.4 Brazil Bioelectric Medicine Market by Application
9.4.5.2 Argentina Bioelectric Medicine Market
9.4.5.2.1 Argentina Bioelectric Medicine Market by Type
9.4.5.2.2 Argentina Bioelectric Medicine Market by End-use
9.4.5.2.3 Argentina Bioelectric Medicine Market by Product
9.4.5.2.4 Argentina Bioelectric Medicine Market by Application
9.4.5.3 UAE Bioelectric Medicine Market
9.4.5.3.1 UAE Bioelectric Medicine Market by Type
9.4.5.3.2 UAE Bioelectric Medicine Market by End-use
9.4.5.3.3 UAE Bioelectric Medicine Market by Product
9.4.5.3.4 UAE Bioelectric Medicine Market by Application
9.4.5.4 Saudi Arabia Bioelectric Medicine Market
9.4.5.4.1 Saudi Arabia Bioelectric Medicine Market by Type
9.4.5.4.2 Saudi Arabia Bioelectric Medicine Market by End-use
9.4.5.4.3 Saudi Arabia Bioelectric Medicine Market by Product
9.4.5.4.4 Saudi Arabia Bioelectric Medicine Market by Application
9.4.5.5 South Africa Bioelectric Medicine Market
9.4.5.5.1 South Africa Bioelectric Medicine Market by Type
9.4.5.5.2 South Africa Bioelectric Medicine Market by End-use
9.4.5.5.3 South Africa Bioelectric Medicine Market by Product
9.4.5.5.4 South Africa Bioelectric Medicine Market by Application
9.4.5.6 Nigeria Bioelectric Medicine Market
9.4.5.6.1 Nigeria Bioelectric Medicine Market by Type
9.4.5.6.2 Nigeria Bioelectric Medicine Market by End-use
9.4.5.6.3 Nigeria Bioelectric Medicine Market by Product
9.4.5.6.4 Nigeria Bioelectric Medicine Market by Application
9.4.5.7 Rest of LAMEA Bioelectric Medicine Market
9.4.5.7.1 Rest of LAMEA Bioelectric Medicine Market by Type
9.4.5.7.2 Rest of LAMEA Bioelectric Medicine Market by End-use
9.4.5.7.3 Rest of LAMEA Bioelectric Medicine Market by Product
9.4.5.7.4 Rest of LAMEA Bioelectric Medicine Market by Application
Chapter 10. Company Profiles
10.1 Medtronic PLC
10.1.1 Company overview
10.1.2 Financial Analysis
10.1.3 Segmental and Regional Analysis
10.1.4 Research & Development Expenses
10.1.5 Recent strategies and developments:
10.1.5.1 Partnerships, Collaborations, and Agreements:
10.1.5.2 Product Launches and Product Expansions:
10.1.5.3 Acquisition and Mergers:
10.1.5.4 Trials:
10.1.6 SWOT Analysis
10.2 Abbott Laboratories
10.2.1 Company Overview
10.2.2 Financial Analysis
10.2.3 Segmental and Regional Analysis
10.2.4 Research & Development Expense
10.2.5 Recent strategies and developments:
10.2.5.1 Partnerships, Collaborations, and Agreements:
10.2.5.2 Product Launches and Product Expansions:
10.2.5.3 Approvals:
10.2.6 SWOT Analysis
10.3 Boston Scientific Corporation
10.3.1 Company Overview
10.3.2 Financial Analysis
10.3.3 Segmental and Regional Analysis
10.3.4 Research & Development Expense
10.3.5 Recent strategies and developments:
10.3.5.1 Product Launches and Product Expansions:
10.3.5.2 Acquisition and Mergers:
10.3.6 SWOT Analysis
10.4 Cochlear Ltd.
10.4.1 Company Overview
10.4.2 Financial Analysis
10.4.3 Segmental and Regional Analysis
10.4.4 Research & Development Expense
10.4.5 Recent strategies and developments:
10.4.5.1 Product Launches and Product Expansions:
10.4.5.2 Geographical Expansions:
10.4.6 SWOT Analysis
10.5 LivaNova PLC
10.5.1 Company Overview
10.5.2 Financial Analysis
10.5.3 Segmental and Regional Analysis
10.5.4 Research & Development Expense
10.5.5 SWOT Analysis
10.6 Koninklijke Philips N.V.
10.6.1 Company Overview
10.6.2 Financial Analysis
10.6.3 Segmental and Regional Analysis
10.6.4 Research & Development Expense
10.6.5 Recent strategies and developments:
10.6.5.1 Acquisition and Mergers:
10.6.6 SWOT Analysis
10.7 Biotronik SE & Co. KG
10.7.1 Company Overview
10.7.2 SWOT Analysis
10.8 Sonova Holding AG
10.8.1 Company Overview
10.8.2 Financial Analysis
10.8.3 Segmental and Regional Analysis
10.8.4 Research & Development Expenses
10.8.5 Recent strategies and developments:
10.8.5.1 Geographical Expansions:
10.8.6 SWOT Analysis
10.9 Nevro Corporation
10.9.1 Company Overview
10.9.2 Financial Analysis
10.9.3 Regional Analysis
10.9.4 Research & Development Expense
10.9.5 Recent strategies and developments:
10.9.5.1 Approvals:
10.9.6 SWOT Analysis
10.10. electroCore, Inc.
10.10.1 Company Overview
10.10.2 Financial Analysis
10.10.3 Regional Analysis
10.10.4 Research & Development Expenses
10.10.5 Recent strategies and developments:
10.10.5.1 Partnerships, Collaborations, and Agreements:
10.10.5.2 Product Launches and Product Expansions:
10.10.6 SWOT Analysis
Chapter 11. Winning imperative of Bioelectric Medicine Market

Companies Mentioned

  • Medtronic PLC
  • Abbott Laboratories
  • Boston Scientific Corporation
  • Cochlear Ltd.
  • LivaNova PLC
  • Koninklijke Philips N.V.
  • Biotronik SE & Co. KG
  • Sonova Holding AG
  • Nevro Corporation
  • electroCore, Inc.

Methodology

Loading
LOADING...